Global Central Nervous System Treatment Market Size and Share By Industry Demand, Worldwide Research, Prominent Players, Emerging Trends, Investment Opportunities and Revenue Expectation till 2027

The global ”central nervous system treatment market“ size is expected to reach USD 166.53 billion by 2028, exhibiting a CAGR of 9.4% during the forecast period. The increasing mergers and acquisitions among prominent players are expected to enable speedy expansion of this market in the forthcoming years, states Fortune Business Insights, in a report, titled “Central Nervous System Treatment Market, 2021-2028.” The market size stood at USD 81.67 billion in 2020.

The spread of coronavirus had a damaging impact on the global market due to the high priority development of COVID-19 vaccines by pharmaceutical companies. However, rising innovation in gene therapy could have a lasting effect on the central nervous system industry amid the pandemic. Moreover, the ongoing R&D activities, coupled with partnership deals among leading companies, can spur lucrative opportunities for the market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/central-nervous-system-treatment-market-103973

Agreement between Neurocrine Biosciences and Voyager Therapeutics to Bolster Growth

Neurocrine Biosciences, a publicly-traded biopharmaceutical company, announced that it signed a deal with Voyager Therapeutics, a biotechnology company to develop and commercialize a series of gene therapy programs for neurodegenerative diseases, including VY-AADC for Parkinson disease. Neurocrine will be funding the ongoing development of each program and $165 million upfront to Voyager and up to $1.7 billion in milestone payments.

Moreover, gene therapy’s inclination due to its favorable outcomes will urge companies to introduce innovative medicines to treat Alzheimer’s disease, Parkinson’s disease, and other neurological diseases. Thus, accelerating the central nervous system treatment Market growth. For instance, in February 2020, Biogen announced a $2.72 billion licensing deal with Sangamo Therapeutics to develop and commercialize gene regulation therapies based on Sangamo’s zinc finger platform to treat Alzheimer disease, Parkinson’s disease, and other neurological diseases. The deal included an upfront payment of $350 million and up to $2.37 billion in milestone payments.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/central-nervous-system-treatment-market-103973

Rising Geriatric Population to Augment Growth  

The increasing prevalence of neurological disorders in elderly population such as multiple sclerosis, Alzheimer’s, Parkinson’s will spur demand for central nervous system treatment. According to the Public Health England, the number of individuals suffering from multiple sclerosis has increased to over 131,000 in the U.K for the year 2018.  The increasing geriatric population with Alzheimer’s can support the development of the market. According to the Alzheimer’s Association, more than five million individuals are affected with Alzheimer’s disease, and this number is set to reach 14 million by 2050. The treatment and care for Alzheimer’s in the US was over US$ 305 Bn in 2020.

Hospital Pharmacy Segment to Hold the Largest Share

Based on the drug type, the market is divided into multiple sclerosis drugs, antipsychotic, anti-epileptic, antidepressants, psychostimulants, narcotic analgesics, non-narcotic analgesics, anesthetics, anti-Parkinson’s, sedatives, general anesthesia, and other CNS drugs.  Multiple sclerosis drugs are expected to hold the largest share due to the perpetual innovation and development of the therapeutic molecule.

Based on the distribution channel, the market is classified into hospital pharmacies, retail pharmacies, and others. The hospital pharmacy segment is expected to hold the lion’s share during the forecast period due to the significant increase in the sales of prescription drugs. The retail pharmacy segment is expected to experience steady growth due to the increasing access to prescription drugs and discounts offered by retail pharmacy giants.

Geographically, the market is divided into North America, Asia Pacific, Latin America, and the Middle East and Africa.

Quick Buy –  Central Nervous System Treatment Market Research Report: 

https://www.fortunebusinessinsights.com/checkout-page/103973

Evolving Healthcare Infrastructure to Encourage Growth in Asia Pacific

  • North America is expected to increase radically during the forecast period due to existing companies in the US. The development of innovative drugs will propel growth in the region.
  • Favorable reimbursement policies and high access to treatment options will aid expansion in Europe.
  • Asia Pacific is expected to increase rapidly during the forecast period due to the surging geriatric population and evolving healthcare infrastructure.
  • The Middle East and Africa is expected to experience sluggish growth due to lack of product approvals and weaker product penetration.

Robust Drug Pipeline to Consolidate Market

The market is dominated by major pharmaceutical companies operating in the central nervous system treatment industry. Robust pipeline and strategic distribution agreements for innovative therapies can uplift the central nervous system treatment market share in the forthcoming years. For instance, Biogen generated significant revenue in the year 2020. Other companies operating in the market include Johnson and Johnson Services, Inc., Pfizer Inc., RF. Hoffman-La Roche Ltd., Novartis AG, Sanofi, Teva Pharmaceutical Industries, Otsuka Holdings, among others.

Have Any Query? Ask Our Experts:  https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/central-nervous-system-treatment-market-103973

The Report Lists the Players in the Central Nervous System Treatment Market:

  • Biogen (Massachusetts, U.S)
  • Pfizer Inc. (New York, U.S)
  • Hoffmann-La Roche Ltd (Switzerland)
  • Novartis AG (Basel, Switzerland)
  • Johnson & Johnson Services, Inc. (New Jersey, U.S)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (Paris, France)
  • Otsuka Holdings (Japan)
  • Other Players

Table of Content:

1 Central Nervous System Treatment Market Overview

1.1 Central Nervous System Treatment Product Overview

1.2 Central Nervous System Treatment Market Segment by Type

1.3 Global Central Nervous System Treatment Market Size by Type (2015-2027)

1.3.1 Global Central Nervous System Treatment Market Size Overview by Type (2015-2027)

1.3.2 Global Central Nervous System Treatment Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Central Nervous System Treatment Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Central Nervous System Treatment Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Central Nervous System Treatment Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Central Nervous System Treatment Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Central Nervous System Treatment Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Central Nervous System Treatment Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Central Nervous System Treatment Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Central Nervous System Treatment Sales Breakdown by Type (2015-2027)

1.4.2 Europe Central Nervous System Treatment Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Central Nervous System Treatment Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Central Nervous System Treatment Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Central Nervous System Treatment Sales Breakdown by Type (2015-2027)

2 Global Central Nervous System Treatment Market Competition by Company

2.1 Global Top Players by Central Nervous System Treatment Sales (2015-2021)

2.2 Global Top Players by Central Nervous System Treatment Revenue (2015-2021)

2.3 Global Top Players Central Nervous System Treatment Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Central Nervous System Treatment Manufacturing Base Distribution, Sales Area, Product Type

2.5 Central Nervous System Treatment Market Competitive Situation and Trends

2.5.1 Central Nervous System Treatment Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Central Nervous System Treatment Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System Treatment as of 2019)

2.7 Date of Key Company Enter into Central Nervous System Treatment Market

2.8 Key Company Central Nervous System Treatment Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Central Nervous System Treatment Status and Outlook by Region (2015-2027)

3.1 Global Central Nervous System Treatment Market Size and CAGR by Region: 2015 VS 2021 VS 2027

3.2 Global Central Nervous System Treatment Market Size Market Share by Region (2015-2021)

3.2.1 Global Central Nervous System Treatment Sales Market Share by Region (2015-2021)

3.2.2 Global Central Nervous System Treatment Revenue Market Share by Region (2015-2021)

3.2.3 Global Central Nervous System Treatment Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Central Nervous System Treatment Market Size Market Share by Region (2021-2027)

3.3.1 Global Central Nervous System Treatment Sales Market Share by Region (2021-2027)

3.3.2 Global Central Nervous System Treatment Revenue Market Share by Region (2021-2027)

3.3.3 Global Central Nervous System Treatment Sales, Revenue, Price and Gross Margin (2021-2027)

3.4 North America Central Nervous System Treatment Market Size By Growth (2015-2027)

3.4.1 North America Central Nervous System Treatment Revenue By Growth (2015-2027)

3.4.2 North America Central Nervous System Treatment Sales By Growth (2015-2027)

3.5 Asia-Pacific Central Nervous System Treatment Market Size By Growth (2015-2027)

3.5.1 Asia-Pacific Central Nervous System Treatment Revenue By Growth (2015-2027)

3.5.2 Asia-Pacific Central Nervous System Treatment Sales By Growth (2015-2027)

3.6 Europe Central Nervous System Treatment Market Size By Growth (2015-2027)

3.6.1 Europe Central Nervous System Treatment Revenue By Growth (2015-2027)

3.6.2 Europe Central Nervous System Treatment Sales By Growth (2015-2027)

3.7 Latin America Central Nervous System Treatment Market Size By Growth (2015-2027)

3.7.1 Latin America Central Nervous System Treatment Revenue By Growth (2015-2027)

3.7.2 Latin America Central Nervous System Treatment Sales By Growth (2015-2027)

3.8 Middle East and Africa Central Nervous System Treatment Market Size By Growth (2015-2027)

3.8.1 Middle East and Africa Central Nervous System Treatment Revenue By Growth (2015-2027)

3.8.2 Middle East and Africa Central Nervous System Treatment Sales By Growth (2015-2027)

4 Global Central Nervous System Treatment by Application

4.1 Central Nervous System Treatment Segment by Application

4.1.1 Residential

4.1.2 Commercial

4.2 Global Central Nervous System Treatment Sales by Application: 2015 VS 2021 VS 2027

4.3 Global Central Nervous System Treatment Historic Sales by Application (2015-2021)

4.4 Global Central Nervous System Treatment Forecasted Sales by Application (2021-2027)

4.5 Key Regions Central Nervous System Treatment Market Size by Application

4.5.1 North America Central Nervous System Treatment by Application

4.5.2 Europe Central Nervous System Treatment by Application

4.5.3 Asia-Pacific Central Nervous System Treatment by Application

4.5.4 Latin America Central Nervous System Treatment by Application

4.5.5 Middle East and Africa Central Nervous System Treatment by Application

5 North America Central Nervous System Treatment Market Size by Country (2015-2027)

5.1 North America Market Size Market Share by Country (2015-2021)

5.1.1 North America Central Nervous System Treatment Sales Market Share by Country (2015-2021)

5.1.2 North America Central Nervous System Treatment Revenue Market Share by Country (2015-2021)

5.2 North America Market Size Market Share by Country (2021-2027)

5.2.1 North America Central Nervous System Treatment Sales Market Share by Country (2021-2027)

5.2.2 North America Central Nervous System Treatment Revenue Market Share by Country (2021-2027)

5.3 North America Market Size By Growth by Country

5.3.1 U.S. Central Nervous System Treatment Market Size By Growth (2015-2027)

5.3.2 Canada Central Nervous System Treatment Market Size By Growth (2015-2027)

6 Europe Central Nervous System Treatment Market Size by Country (2015-2027)

6.1 Europe Market Size Market Share by Country (2015-2021)

6.1.1 Europe Central Nervous System Treatment Sales Market Share by Country (2015-2021)

6.1.2 Europe Central Nervous System Treatment Revenue Market Share by Country (2015-2021)

6.2 Europe Market Size Market Share by Country (2021-2027)

6.2.1 Europe Central Nervous System Treatment Sales Market Share by Country (2021-2027)

6.2.2 Europe Central Nervous System Treatment Revenue Market Share by Country (2021-2027)

6.3 Europe Market Size By Growth by Country

6.3.1 Germany Central Nervous System Treatment Market Size By Growth (2015-2027)

6.3.2 France Central Nervous System Treatment Market Size By Growth (2015-2027)

6.3.3 U.K. Central Nervous System Treatment Market Size By Growth (2015-2027)

6.3.4 Italy Central Nervous System Treatment Market Size By Growth (2015-2027)

6.3.5 Russia Central Nervous System Treatment Market Size By Growth (2015-2027)

7 Asia-Pacific Central Nervous System Treatment Market Size by Country (2015-2027)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)

7.1.1 Asia-Pacific Central Nervous System Treatment Sales Market Share by Country (2015-2021)

7.1.2 Asia-Pacific Central Nervous System Treatment Revenue Market Share by Country (2015-2021)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)

7.2.1 Asia-Pacific Central Nervous System Treatment Sales Market Share by Country (2021-2027)

7.2.2 Asia-Pacific Central Nervous System Treatment Revenue Market Share by Country (2021-2027)

7.3 Asia-Pacific Market Size By Growth by Country

7.3.1 China Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.2 Japan Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.3 South Korea Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.4 India Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.5 Australia Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.6 Taiwan Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.7 Indonesia Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.8 Thailand Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.9 Malaysia Central Nervous System Treatment Market Size By Growth (2015-2027)

7.3.10 Philippines Central Nervous System Treatment Market Size By Growth (2015-2027)

Toc Continue…

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/central-nervous-system-treatment-market-103973

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: [email protected]

Related Reports :

Germany Hepatitis C Testing Market 

Immunomodulators Market 

Latin America Eyewear Market 

Point-of-care Ultrasound Market 

Portable Ultrasound Market 

Infectious Disease Point of Care Diagnostics Market 

Medical X-ray Market 

Point of Care (POC) CT Imaging Systems Market 

Central Nervous System Treatment Market 

Dental CAD/CAM Market 

Germany Hepatitis C Testing Market Size

Immunomodulators Market Size

Latin America Eyewear Market Size

Point-of-care Ultrasound Market Size

Portable Ultrasound Market Size

Latin America Eyewear Market 

Point-of-care Ultrasound Market 

Infectious Disease Point of Care Diagnostics Market Size

Medical X-ray Market Size

Point of Care (POC) CT Imaging Systems Market Size

Central Nervous System Treatment Market Size

Dental CAD/CAM Market Size

Leave a Reply

Your email address will not be published. Required fields are marked *

Close